Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
HCP Journey Mapping the Missing Link in Pharma Marketing ROI
HCP journey mapping is no longer optional. It is the backbone of omnichannel marketing pharma. Without it, campaigns collapse into silos and every rupee spent becomes hard to justify. Indian pharma…
|
Omnichannel Marketing Pharma Practical Playbook for India
Indian pharma is at a turning point. For decades, field reps carried the weight of marketing on their shoulders. Today, the model has shifted. Doctors expect meaningful engagement across multiple…
|
UCPMP 2024 Guidelines: What Every Pharma Marketer Needs to Know
The UCPMP 2024 guidelines are not just another regulatory update. They mark a decisive shift in how pharmaceutical marketing in India will be judged, tracked, and held accountable. For years, pharma…
|
Five Proven Ways to Cut MLR Approval Time in Pharma
Do you know why MLR approval is the silent killer of pharma campaigns? Every pharma marketer in India knows the frustration. You have a campaign ready, the creative is aligned, the channels are set,…
